Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price - Overview

Stock Report

Alexion Pharmaceuticals Inc ALXN

Last Price
$139.02

Day Change
-1.44|-1.03%

As of 20/10/2017
17:08:39 EDT | USD
Minimum 15 Minutes Delay.

Last Close140.46
Day Range137.48 - 140.48
Mkt Cap31.03Bil
52-Wk Range96.18 - 149.34
Yield %-
ISINUS0153511094
Volume2,079,611
P/E60.18
P/S9.23
P/CF24.97

Share Price

Financials
201420152016
More ...
Income Statement
Revenue2,233.732,604.053,084.00
Operating Income868.71536.67667.00
Net Income656.91144.39399.00
Basic EPS3.320.681.78
Avg. Diluted Shares Outstanding202216227
Balance Sheet
Current Assets2,796.032,425.352,578.00
Non Current Assets1,405.9310,707.8810,675.00
Total Assets4,201.9613,133.2313,253.00
Current Liabilities606.74718.25823.00
Total Liabilities899.944,874.614,559.00
Total Equity3,302.028,258.628,694.00
Cash Flow
Operating Cash Flow640.08675.201,086.00
Capital Expenditure-136.65-286.34-333.00
Free Cash Flow503.43388.86753.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Alexion Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

3,121
Key Stats
More ...
Price/Earning TTM60.28
Price/Book3.53
Price/Sales TTM9.32
Rev Growth (3 year avg)25.74
EPS Growth (3 year avg)-
Operating Margin % TTM21.63
Net Margin % TTM12.94
ROE TTM4.71
Debt/Equity0.36
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.